Akari Therapeutics As Of March 31, 2024, The Company Had Cash Of ~$1.3M
Portfolio Pulse from Benzinga Newsdesk
Akari Therapeutics reported having approximately $1.3 million in cash as of March 31, 2024.
May 16, 2024 | 12:23 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Akari Therapeutics reported having approximately $1.3 million in cash as of March 31, 2024. This low cash balance may raise concerns about the company's liquidity and ability to fund operations in the short term.
The reported cash balance of $1.3 million is relatively low, which may raise concerns about Akari Therapeutics' ability to sustain its operations without additional funding. This could negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100